Welcome to Arimidex.net, this website is an international information resource for healthcare professionals with an interest in breast cancer treatment. This website is not intended to replace the advice of a qualified healthcare professional. If you are in the US you should visit Arimidex US. If you are in the UK you should visit the UK site. If you are a patient you should visit the Patient site. If you are a journalist you should visit the AstraZeneca Press Office. This website is provided by AstraZeneca.




Switching from adjuvant tamoxifen to ARIMIDEX treatment for early breast cancer improves overall survival

Switching adjuvant therapy from tamoxifen to ARIMIDEX (anastrozole) allows postmenopausal women with early breast cancer to live cancer-free for longer (The Lancet 5 August)

Podcasts
Lectures in Early Breast Cancer is an educational series that summarizes the latest and most pertinent findings concerning the epidemiology, pathology, diagnosis, and management of early breast cancer.